You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 9, September 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Correspondence
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Neurology
 •Cerebrovascular Disease
 •Stroke
 •Ophthalmology
 •Vitreous Disorders
 •Cardiovascular System
 •Radiologic Imaging
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Thrombolysis in Acute Ischemic Stroke With Vitreous Hemorrhage

Shyam S. Moudgil, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Ahmad and colleagues1 is of great interest. The authors describe a 70-year-old man presenting to the hospital with an acute ischemic infarction. Systemic thrombolysis was withheld because of the vitreous hemorrhage. I, however, respectfully disagree with their decision. This patient had a major stroke that affected the dominant cerebral hemisphere. If left untreated, he would have devastating neurological sequela and, if treated with thrombolytics, it may have worsened the vitreous hemorrhage.

One of the 2 most important considerations in such a patient is the duration of the vitreous hemorrhage. A relatively older vitreous hemorrhage is less likely to rebleed. Second, preexisting visual and ocular status should be assessed. Presence of proliferative retinopathy may indicate poor vision at baseline. Knowledge of these 2 parameters would help in shared decision-making between the patient and physician. The patient should be educated about the risk of worsening . . . [Full Text of this Article]

AUTHOR INFORMATION



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Would You Perform Thrombolysis in This Acute Ischemic Stroke Patient?
Aftab Ahmad, Hock L. Teoh, and Vijay K. Sharma
Arch Neurol. 2009;66(3):410-411.
EXTRACT | FULL TEXT  

RELATED LETTER

Thrombolysis in Acute Ischemic Stroke With Vitreous Hemorrhage—Reply
Aftab Ahmad, Hock L. Teoh, and Vijay K. Sharma
Arch Neurol. 2009;66(9):1178-1179.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.